Venetoclax w Rituximab progressed the furthest Phase 3 Data shows the combination is superior
Matthew S. Davids, MD, MMSc, talks about how Venetoclax w Rituximab progressed the furthest Phase 3 Data shows the combination is superior Imedex Great Debates 2018.
Author: hematologydebates
Added: 05/08/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts